Journal Of Oncology Practice Podcast

Barriers to Prescribing Crizotinib Following FDA Approval

Informações:

Sinopsis

by Robert S. Miller, MD. Dr. Nathan Pennell discusses some of the interesting obstacles he encountered when trying to prescribe crizotinib for 3 patients with ALK positive non-small cell lung cancer in the first few weeks following FDA approval in 2011.